Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

February 13, 2018

Study Completion Date

February 13, 2018

Conditions
Sensitive Skin
Interventions
OTHER

P926 - LICHTENA DermAD CREMA VISO

The study product was applied on a skin areas of about 14 cm2 of the forearm, defined turning on the right and left side in accordance with a randomization list, on which an erythema has been experimentally induced by repeated tape stripping.

OTHER

P927 - LICHTENA DermAD CREMA CORPO

The study product was applied on a skin areas of about 14 cm2 of the forearm, defined turning on the right and left side in accordance with a randomization list, on which an erythema has been experimentally induced by repeated tape stripping.

OTHER

P926 - LICHTENA DermAD CREMA VISO - PLACEBO

The study product was applied on a skin areas of about 14 cm2 of the forearm, defined turning on the right and left side in accordance with a randomization list, on which an erythema has been experimentally induced by repeated tape stripping.

OTHER

Untreated control area

Untreated skin area of about 14 cm2 of the forearm, defined turning on the right and left side in accordance with a randomization list, on which an erythema has been experimentally induced by repeated tape stripping.

Trial Locations (1)

20149

DERMING, Milan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Derming SRL

OTHER

NCT03464890 - Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area | Biotech Hunter | Biotech Hunter